Palvella Therapeutics, Inc. PVLA

Set alert

162.28 USD +9.35 (+6.11%)

At closeNov 4, 2026, 4:26 PM EST

162.28 0.00 0.00%

After hours · Nov 4, 4:26 PM ET

147.47 Day range 163.75

72.23 52-week range 163.75

Held by insiders 11.21%

Held by institutions 105.04%

Float held by institutions 118.31%

Institutions 280

Top institutional holders
Holder	% held	Shares	Value	Reported
Montanova Capital LLC	7.88%	1,135,406	184.25M	Jun 29, 2026
Jennison Associates LLC	6.67%	960,619	155.89M	Jun 29, 2026
Blackrock Inc.	6.37%	918,357	149.03M	Jun 29, 2026
Frazier Life Sciences Management, L.P.	6.12%	882,400	143.20M	Jun 29, 2026
First Light Asset Management, LLC	5.36%	771,901	125.26M	Jun 29, 2026
BVF Inc.	4.67%	672,789	109.18M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.70%	388,390	63.03M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.51%	362,314	58.80M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.14%	308,699	50.10M	Sep 29, 2026
Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund	1.92%	276,556	44.88M	Jul 30, 2026
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund	1.61%	231,484	37.57M	Jun 29, 2026
PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund	1.47%	212,225	34.44M	Sep 29, 2026

PVLA insiders
Insider	Relation	Latest transaction	Date	Shares held
GOIN KATHLEEN	Chief Operating Officer	Sale	Aug 18, 2026	0
HERON ELAINE J	Director	Purchase	Feb 26, 2026	53,691
JENKINS GEORGE M	Director	Sale	Oct 13, 2026	146,132
KIRITSY CHRISTOPHER P	Director	Sale	Sep 1, 2026	250
KORENBERG MATTHEW E	Chief Financial Officer	Conversion of Exercise of derivative security	Jun 11, 2026	1,000

Held by funds